• Where Quality is Paramount

  • Existing customer?


Pharmacy News

Latest News – PSNC Main site
Pharmaceutical Services Negotiating Committee

Feedback on our Future of Pharmacy Animation
Please share your thoughts with us Last month PSNC launched a video animation explaining how community pharmacy will fit into the NHS of the future. The animation should help contractors to understand what will be expected of pharmacies in the future and how they can start to prepare for that. We would like to hear...

MHRA Drug Safety Update May 2019
Date issued: 17th May 2019 A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 10 May 2019:1) has been published and includes articles on: Lemtrada (alemtuzumab) and serious cardiovascular and immune-mediated adverse reactions: new restrictions to use and strengthened monitoring requirements. Tofacitinib (Xeljanz ▼) : restriction of 10mg twice-daily...

CPAF screening process to start in June
The 2019/20 Community Pharmacy Assurance Framework (CPAF) screening questionnaire will soon be available for completion from Monday 3rd June 2019 until Sunday 30th June 2019. The process asks all NHS community pharmacy contractors to complete a short screening questionnaire consisting of 10 active questions which should be answered; NHS England will then select a small...

Sinemet – Supply update and notice of change of appearance
Supply Update Merck Sharp & Dohme Limited (MSD) are still experiencing intermittent supply issues which are expected to continue until early June with the following products: Sinemet 25mg/250mg 10×10 tablets. Sinemet 12.5mg/50mg 9×10 tablets. Sinemet CR 50mg/200mg 6×10 tablets. Sinemet plus 10mg/100mg 10×10 tablets. MSD have confirmed the following Sinemet products should now be available:...

PCSE invitation to contractors to test market entry online portal
In March, PSNC announced that market-entry applications were to move online as PCSE confirmed a new approach for pharmacy applications which will see the replacement of multiple paper forms with one single online application, accessible via PCSE Online. PSNC has been and will continue to work with PCSE on the development of the market-entry online...

Book now for our Schedule of Payments webinar
PSNC and the NHS Business Services Authority (NHSBSA) will be holding a Schedule of Payments webinar on Tuesday 11th June at 7.30pm. The webinar will aim to help community pharmacy contractors to better understand their FP34 Schedule of Payments. Webinar Details When is it? Tuesday 11th June at 7.30pm. Who should attend Every community pharmacy contractor...

Opportunity to develop community pharmacy across Kent
Are you an exceptional strategic thinking individual who can provide innovative solutions to support and develop community pharmacy? If so, we may have the ideal job opportunity for you. Kent Local Pharmaceutical Committee (LPC) is looking to recruit a new Chief Executive Officer. This exciting key leadership full time role offers the perfect opportunity for an...

Update: are you faxing to the intended recipient?
Further to a news story published earlier this year, NHS England has received further reports from the same hotel chain of faxes being received from pharmacies, which were not intended for the hotel. The hotel chain in question (fax number 0330 333 2812), which has been receiving faxes containing anonymised prescriptions, has a very similar...

Class 2 MHRA Medicines Recall – Co-amoxiclav 125mg/31.25mg/5ml & 250mg/62.5mg/5ml powder for oral suspension (Sandoz Ltd)
Drug alert number: EL (19) A/12 Date issued: 13th May 2019  The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 pharmacy level medicines recall, to be actioned within 48 hours, for certain batches of co-amoxiclav 125mg/31.25mg/5ml powder for oral suspension and 250mg/62.5mg/5ml powder for oral suspension. Sandoz Limited is recalling the...

Delay in distribution of promotional materials for children’s oral health campaign
Colgate-Palmolive has advised that the distribution of their promotional materials for the NHS England children’s oral health campaign has been delayed; therefore community pharmacy contractors will now receive these materials week commencing 13th May 2019. The NHS England community pharmacy oral health campaign is due to start on Monday 13th May 2019, which means contractors...

Feeds from PSNC

Global Pharmaceutical News

PharmaTimes: PharmaTimes Website RSS
PharmaTimes - The latest news in healthcare and life sciences - PharmaTimes Website RSS

AZ Symbicort reduces rate of asthma attacks
The results showed a a 51% reduction in the rate of annual asthma exacerbations compared to albuterol.

Owlstone Medical, Actelion team up for pulmonary hypertension detection
Currently, early diagnosis of PH is very difficult and a delay of years between the onset of symptoms and diagnosis and treatment is unfortunately common.

‘Record’ number of patients taking part in clinical trials
Over 870,250 participants were involved in NIHR supported health and social care studies over the last twelve months.

New screening to help detect Group B Strep in pregnant women
The UK is one of the only countries in the developed world where there is currently no standard screening programme for the bug.

Europeans at risk of chronic digestive diseases due to poor diets
High consumption of ultra-processed foods also increases the prevalence of obesity.

EMA’s PRAC to review Xeljanz and recommends fenspiride withdrawl
The committee has announced its latest meeting highlights.

ChargePoint Technology appoints Stephen Eastick as UK sales manager

NICE recommends Revlimid as multiple myeloma alternative
The new indication will benefit approximately 2,100 patients.

Rise in bowel cancer numbers among young adults
The researchers retrieved data on 143.7 million people aged 20 to 49 years from 20 European countries.

Revlimid, Imnovid combos receive EU approval
The approval of these combination therapies “Marks a significant milestone for patients with multiple myeloma in Europe".

Fragmin approved by FDA as first anticoagulant for children
The drug was initially approved by the FDA in 1994 for adults and is a type of heparin.

Winners announced - 2019 International Clinical Researcher of the Year!
The winners of the PharmaTimes International Clinical Researcher of the Year have been announced, find out who emerged victorious in the 2019 competition.

ICR launches ‘Darwinian’ cancer drug programme
The programme is to be launched in a £75 million state-of-the-art global centre of expertise in anti-evolution therapies in London.

New tech to protect prostate cancer patients during radiation treatment
SpaceOAR hydrogel acts as a spacer, reducing the amount of radiation that can pass through the prostate and damage the rectum during treatment.

AZ confirms cardiovascular safety with roxadustat results
The companies will begin discussions with the US Food and Drug Administration (FDA) to prepare for regulatory submission.


CPhl worldwide

Thame Laboratories will network among the industry’s key players

Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.

Find out more: https://www.cphi.com/europe/

Have you got any questions about our products? We're here to help